Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes mellitus: A report of two cases

Noriko Fujiwara, Mayu Watanabe, Akihiro Katayama, Yohei Noda, Jun Eguchi, Hitomi Kataoka, Shunsuke Kagawa, Jun Wada

Research output: Contribution to journalArticlepeer-review

Abstract

Immune checkpoint inhibitor-induced diabetes mellitus is a rare immune-related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes.

Original languageEnglish
Article numbere04574
JournalClinical Case Reports
Volume9
Issue number9
DOIs
Publication statusPublished - Sep 2021

Keywords

  • C-peptide
  • diabetes mellitus
  • immune checkpoint inhibitor
  • insulin secretion

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes mellitus: A report of two cases'. Together they form a unique fingerprint.

Cite this